CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Diasorin S.P.A. Company Snapshot
Diasorin S.P.A. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Diasorin S.P.A. with three other pharmaceutical manufacturers in Europe: Biotest AG of Germany (2016 sales of 553.10 million Euro [US$660.81 million] of which 63% was Therapy), Boiron SA of France (614.49 million Euro [US$734.15 million] of which 51% was Non-Proprietary Homeopathic Medicines), and Siegfried Holding AG which is based in Switzerland (717.73 million Swiss Francs [US$746.08 million] of which 78% was Drug Substances).

Sales Analysis. During the year ended December of 2016, sales at Diasorin S.P.A. were 569.31 million Euro (US$680.18 million). This is an increase of 14.0% versus 2015, when the company's sales were 499.18 million Euro. This was the fourth straight year of sales growth at Diasorin S.P.A..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Diasorin S.P.A.
  Stock Performance Chart for Diasorin S.P.A.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/15/2017): 73.10
(Figures in Euro)
1 Week -0.6%   13 Weeks 2.2%  
4 Weeks 2.5%   52 Weeks 28.4%  
 
Diasorin S.P.A. Key Data:
  Ticker: DIA Country: Italy
  Exchanges: ISE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 569,312,000
(Year Ending Jan 2017).
Employees: 1,841
  Currency: Euro Market Cap: 4,002,832,242
  Fiscal Yr Ends: December Shares Outstanding: 54,758,307
  Share Type: Azioni Ordinaire Closely Held Shares: 31,943,658
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.